Chen Po-Jui, Chang Yi-Sheng, Lim Chen-Chee, Lee Yu-Kuei
Department of Ophthalmology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Department of Ophthalmology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
Vaccines (Basel). 2022 Feb 25;10(3):363. doi: 10.3390/vaccines10030363.
Due to the COVID-19 pandemic, numerous vaccines have been developed for the disease. However, with large-scale vaccination has come the gradual emergence of immunological phenomena caused by these new vaccines. Herein, we report a 48-year-old female with a sudden onset of inferior visual field defects in the left eye following her first dose of the ChAdOx1 vaccine. Dilated fundus examination combined with optical coherence tomography and fluorescein angiography confirmed the diagnosis of branch retinal artery occlusion. Within 4 weeks following vaccination, symptoms associated with hearing impairment developed, and magnetic resonance imaging revealed leptomeningeal enhancement. The diagnosis of Susac syndrome (SS) was confirmed. The development of SS may be caused by endotheliopathy resulting from the molecular mimicry of the ChAdOx1 vaccine. Clinicians should be aware of the symptoms of SS, which may develop after COVID-19 vaccination. Further experimental surveillance and case-control studies are required to confirm this relationship.
由于新冠疫情,已研发出多种针对该疾病的疫苗。然而,随着大规模疫苗接种,这些新疫苗引发的免疫现象逐渐显现。在此,我们报告一名48岁女性,在接种第一剂ChAdOx1疫苗后左眼突然出现下视野缺损。散瞳眼底检查结合光学相干断层扫描和荧光素血管造影确诊为视网膜分支动脉阻塞。接种疫苗后4周内,出现了与听力障碍相关的症状,磁共振成像显示软脑膜强化。确诊为Susac综合征(SS)。SS的发生可能是由ChAdOx1疫苗的分子模拟导致的内皮病变引起的。临床医生应了解SS的症状,这些症状可能在新冠疫苗接种后出现。需要进一步的实验监测和病例对照研究来证实这种关系。